TotalLab’s Steven Dodd Speaks on the Future of Host Cell Protein Analysis in Biotherapeutics
Accurate analysis of host cell proteins (HCPs) has become a critical requirement in biotherapeutic development, with the safety, efficacy, and regulatory compliance of new drugs relying heavily on reliable HCP quantification. Yet, many laboratories find themselves constrained by the limitations of traditional methods, such as ELISA, 2D-PAGE, and Western Blotting, which can introduce variability, complexity, and reproducibility issues into the workflow.
Today, TotalLab is proud to share that our Head of Sales and Business Development, Steven Dodd, was invited to speak about these challenges and the innovative ways our software is helping laboratories overcome them at the National Horizon's Centre in Darlington. Addressing industry leaders and researchers, Steven highlighted the technical obstacles facing scientists performing HCP analysis in modern biologics development pipelines.
He explained how manual and semi-automated approaches in ELISA, 2D-PAGE, and Western Blot often fall short in providing the consistency and accuracy required for regulatory submission and long-term product safety. Furthermore, the increasing adoption of LC-MS techniques for HCP analysis amplifies the need for robust, reproducible data workflows.
TotalLab’s suite of software solutions directly addresses these concerns by introducing automation and ensuring reproducibility at every stage of the HCP analysis process. Our platforms streamline workflows for ELISA, 2D-PAGE, Western Blotting, and LC-MS, empowering scientists to achieve higher precision, reduce process variability, and enhance compliance with regulatory standards.
By leveraging TotalLab’s automated solutions, biotherapeutic developers can benefit from:
Consistent and reproducible HCP analysis results
Reduced hands-on time and human error
Seamless quantitative workflows for ELISA, 2D-PAGE, Western Blot, and LC-MS
Enhanced scientific confidence and accelerated regulatory submission
TotalLab remains dedicated to supporting biopharmaceutical innovation by delivering powerful, automated tools that simplify the complex world of host cell protein analysis.
Interested in learning more about how TotalLab can help your team enhance HCP quantification workflows? Contact us to schedule a demo or discover more about our software for host cell protein analysis in drug development.